Tae Kon Kim

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

Maximilian Stahl, Michelle DeVeaux, Pau Montesinos et al. · Blood Advances · 2018 · 149 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

A Burned-Out CD8+ T-cell Subset Expands in the Tumor Microenvironment and Curbs Cancer Immunotherapy

Miguel F. Sanmamed, Xinxin Nie, Shruti Desai et al. · Cancer Discovery · 2021 · 148 citations · Full text

Medicine, Immunology, Oncology +17

PD-1H (VISTA)–mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus

Xue Han, Matthew D. Vesely, Wendy Yang et al. · Science Translational Medicine · 2019 · 131 citations

Life Sciences, Immunology, Pathology +17

MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner

Takero Shindo, Tae Kon Kim, Cara L. Benjamin et al. · Blood · 2013 · 53 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Vitamin D receptor upregulation in alloreactive human T cells

Richard W. Joseph, Ulas D. Bayraktar, Tae Kon Kim et al. · Human Immunology · 2012 · 43 citations

Life Sciences, Immunology, Molecular Biology +14